Search results
Showing 691 to 705 of 2044 results for guidelines
A quick guide for registered managers of mental health services for young people
Evidence-based recommendations on myocardial perfusion scintigraphy for diagnosing and managing angina and myocardial infarction in adults.
Get expert advice and support from NICE International, part of the UK’s National Institute for Health and Care Excellence, for a project in your country
Mirabegron for treating symptoms of overactive bladder (TA290)
Evidence-based recommendations on mirabegron (Betmiga) for treating overactive bladder in adults.
Evidence-based recommendations on SonoVue (sulphur hexafluoride microbubbles) for contrast-enhanced ultrasound imaging of the liver
Tests in secondary care to identify people at high risk of ovarian cancer (DG31)
Evidence-based recommendations on tests in secondary care to identify people at high risk of ovarian cancer. The tests are the IOTA ADNEX model, Overa (MIA2G)
Helping to prevent winter deaths and illnesses associated with cold homes
A quick guide for home care managers on preventing deaths and illnesses associated with cold homes.
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules (DG46)
Evidence-based recommendations on EarlyCDT Lung for assessing the risk of lung cancer in solid lung nodules
Digital support for children and young people with eating disorders:early value assessment
Awaiting development [GID-HTE10058] Expected publication date: TBC
NICE's impact on transition from children’s to adults’ services
Guide for young people and their families about being assessed for autism
Summary of the evidence on insulin degludec for treating type 2 diabetes to inform local NHS planning and decision-making
Complicated intra-abdominal infections: ceftolozane/tazobactam (ESNM75)
Summary of the evidence on ceftolozane/tazobactam for treating complicated intra-abdominal infections to inform local NHS planning and decision-making
Awaiting development [GID-QS10094] Expected publication date: TBC
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B (TA96)
Evidence-based recommendations on adefovir dipivoxil (Hepsera) and peginterferon alfa-2a (Pegasys) for treating chronic hepatitis B in adults.